Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients

Affiliations

• ¹ Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
• ² Oxford University Clinical Academic Graduate School, Oxford, UK.
• ³ Department of Haematology, Laiko General Hospital, Athens, Greece.
• ⁴ University Hospital Southampton, Southampton, UK.
• ⁵ Milton Keynes Hospital, Milton Keynes, UK.
• ⁶ Birmingham Heartlands Hospital, Birmingham, UK.
• ⁷ Good Hope Hospital, Birmingham, UK.
• ⁸ Solihull Hospital, Birmingham, UK.
• ⁹ West Midlands Research Consortium (WMRC), West Midlands, UK.
• ¹⁰ The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
• ¹¹ Royal Derby Hospital, Derby, UK.
• ¹² Queen Elizabeth Hospital, Birmingham, UK.
• ¹³ Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
• ¹⁴ Royal Berkshire Hospital, Reading, UK.
• ¹⁵ Guy's and St Thomas NHS Foundation Trust, London, UK.
• ¹⁶ University Hospital of UK, London, UK.
• ¹⁷ University Hospitals Sussex NHS Foundation Trust, Chichester, UK.
• ¹⁸ Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
• ¹⁹ University Hospital Crosshouse, Crosshouse, UK.
• ²⁰ Stoke Mandeville Hospital, Aylesbury, UK.
• ²¹ Royal United Hospital Bath, Bath, UK.
• ²² Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
• ²³ Poole Hospital, Poole, UK.
• ²⁴ Beatson Oncology Centre, Glasgow, UK.
• ²⁵ Manchester Royal Infirmary, Manchester, UK.
• ²⁶ Great Western Hospital, Swindon, UK.
• ²⁷ Wexham Park Hospital, Slough, UK.
• ²⁸ University of Wolverhampton, Wolverhampton, UK.